Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation

Metabolic considerations of drugs in the treatment of allergic diseases

(2013) Elena García-Martín et al.   Expert Opinion on Drug Metabolism & Toxicology

Indacaterol

(2012) Kate McKeage   DRUGS

Systemic pharmacokinetics of indacaterol, an inhaled once-daily long-acting ?2-agonist, in different ethnic populations

(2012) Soichiro Matsushima et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Validation of an on-line solid-phase extraction method coupled to liquid chromatography–tandem mass spectrometry detection for the determination of Indacaterol in human serum

(2012) Corinne Emotte et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol

(2012) Mario Cazzola et al.   RESPIRATORY MEDICINE

Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily beta2-agonist bronchodilator, in subjects with COPD

(2011) S. Pascoe et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study

(2011) Sanjeev Khindri et al.   BMC Pulmonary Medicine

Safety of indacaterol in the treatment of patients with COPD

(2011) James Donohue et al.   International Journal of Chronic Obstructive Pulmonary Disease

Efficacy, Safety and Pharmacokinetics of Indacaterol in Caucasian and Japanese Patients with Chronic Obstructive Pulmonary Disease

(2010) Motoi Hosoe et al.   CLINICAL DRUG INVESTIGATION

The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist

(2010) François Baur et al.   JOURNAL OF MEDICINAL CHEMISTRY

Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design

(2010) Peter J. Barnes et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Indacaterol once-daily is equally effective dosed in the evening or morning in COPD

(2010) H. Magnussen et al.   RESPIRATORY MEDICINE

Lipid membrane interactions of indacaterol and salmeterol: Do they influence their pharmacological properties?

(2009) Dario Lombardi et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison

(2008) Stephen Rennard et al.   RESPIRATORY MEDICINE